P&G Reports Strong Q3 2025 Earnings: Net Profit Up 12.24%, Sales Rise

• Procter & Gamble Hygiene and Health Care's standalone net sales reached Rs 1,261.90 crore in December 2025, a 1.14% increase year-on-year.
• Quarterly net profit surged by 12.24% to Rs 301.46 crore in December 2025, compared to Rs 268.59 crore in December 2024.
• EBITDA for December 2025 stood at Rs 414.21 crore, marking an 8.82% rise from the previous year.
• Earnings Per Share (EPS) increased to Rs 92.87 in December 2025 from Rs 82.74 in December 2024.
• P&G shares closed at Rs 11,787.00 on February 01, 2026, experiencing negative returns of -13.38% over 6 months and -19.33% over 12 months.

Why It Matters: P&G reported robust December 2025 quarterly results with significant profit and sales growth despite stock declines.